安纳普蒂斯生物

最新新闻

• 评级变动
  TD Cowen Maintains AnaptysBio(ANAB.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/25
• 评级变动
  TD Cowen Maintains AnaptysBio(ANAB.US) With Buy Rating, Announces Target Price $75
  \u5e02\u573a\u8d44\u8baf · 2026/4/27
• 评级变动
  TD Cowen Maintains AnaptysBio(ANAB.US) With Buy Rating, Cuts Target Price to $70
  \u5e02\u573a\u8d44\u8baf · 2026/8/25
• 评级变动
  Piper Sandler Maintains AnaptysBio(ANAB.US) With Buy Rating, Maintains Target Price $93
  \u5e02\u573a\u8d44\u8baf · 2026/7/22
• 评级变动
  A Quick Look at Today's Ratings for AnaptysBio(ANAB.US), With a Forecast Between $75 to $93
  \u5e02\u573a\u8d44\u8baf · 2026/5/13
• 评级变动
  TD Cowen Maintains AnaptysBio(ANAB.US) With Buy Rating, Maintains Target Price $75
  \u5e02\u573a\u8d44\u8baf · 2026/7/13
• 评级变动
  Barclays Maintains AnaptysBio(ANAB.US) With Buy Rating, Maintains Target Price $75
  \u5e02\u573a\u8d44\u8baf · 2026/9/23
• 评级变动
  UBS Maintains AnaptysBio(ANAB.US) With Buy Rating, Raises Target Price to $76
  \u5e02\u573a\u8d44\u8baf · 2026/5/13
• 评级变动
  Piper Sandler Maintains AnaptysBio(ANAB.US) With Buy Rating, Cuts Target Price to $93
  \u5e02\u573a\u8d44\u8baf · 2026/5/4
• 公司公告
  AnaptysBio: Anaptys Biosciences, Inc. - Distribution Option Symbol: ANAB New Symbol: ANAB1
  OCC · 2026/4/7
• H.C. Wainwright Maintains AnaptysBio(ANAB.US) With Buy Rating, Maintains Target Price $95
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• AnaptysBio (ANAB) Gets a Buy From H.C. Wainwright
  TipRanks · 2026/10/5
• 评级变动
  Leerink Partners Maintains AnaptysBio(ANAB.US) With Buy Rating, Raises Target Price to $90
  \u5e02\u573a\u8d44\u8baf · 2026/5/15
• UBS Maintains AnaptysBio(ANAB.US) With Buy Rating, Maintains Target Price $76
  \u5e02\u573a\u8d44\u8baf · 2026/9/22
• Leerink Partners Maintains AnaptysBio(ANAB.US) With Buy Rating, Announces Target Price $81
  \u5e02\u573a\u8d44\u8baf · 2026/9/23
• 评级变动
  J.P. Morgan Maintains AnaptysBio(ANAB.US) With Buy Rating, Raises Target Price to $70
  \u5e02\u573a\u8d44\u8baf · 2026/5/23
• 评级变动
  H.C. Wainwright Initiates AnaptysBio(ANAB.US) With Buy Rating, Announces Target Price $95
  \u5e02\u573a\u8d44\u8baf · 2026/6/10
• 评级变动
  Leerink Partners Maintains AnaptysBio(ANAB.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/5/27
• 评级变动
  Leerink Partners Maintains AnaptysBio(ANAB.US) With Buy Rating, Announces Target Price $85
  \u5e02\u573a\u8d44\u8baf · 2026/4/28
• J.P. Morgan Maintains AnaptysBio(ANAB.US) With Buy Rating, Cuts Target Price to $60
  \u5e02\u573a\u8d44\u8baf · 2026/9/30

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。